Evidence map›Paper›PMID 25333064›Full record

ArticleMolecular genetics & genomic medicine2014

Screening for single nucleotide variants, small indels and exon deletions with a next-generation sequencing based gene panel approach for Usher syndrome.

Peter M Krawitz, Daniela Schiska, Ulrike Krüger, Sandra Appelt, Verena Heinrich, Dmitri Parkhomchuk, Bernd Timmermann, Jose M Millan, Peter N Robinson, Stefan Mundlos and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Structural modeling, mutation analysis, andComputational and structural biotechnology journal · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. VisCap: inference and visualization of germ-line copy-number variants from targeted clinical sequencing data.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Peter M KrawitzInstitute for Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin Berlin, Germany.
Daniela SchiskaDepartment of Audiology and Phoniatrics, Charité Universitätsmedizin Berlin Berlin, Germany.
Ulrike KrügerInstitute for Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin Berlin, Germany.
Sandra AppeltInstitute for Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin Berlin, Germany.
Verena HeinrichInstitute for Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin Berlin, Germany.
Dmitri ParkhomchukInstitute for Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin Berlin, Germany.
Bernd TimmermannMax Planck Institute for Molecular Genetics Berlin, Germany.
Jose M MillanUnidad de Genetica, Hospital Universitario La Fe and CIBERER Valencia, Spain.
Peter N RobinsonInstitute for Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin Berlin, Germany.
Stefan MundlosInstitute for Medical Genetics and Human Genetics, Charité Universitätsmedizin Berlin Berlin, Germany.
Jochen HechtBerlin Brandenburg Center for Regenerative Therapies BCRT Berlin, Germany.
Manfred GrossDepartment of Audiology and Phoniatrics, Charité Universitätsmedizin Berlin Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEBerlin-Brandenburger Centrum für Regenerative Therapien · DEHospital Universitari i Politècnic La Fe · ESMax Planck Institute for Molecular Genetics · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Usher syndrome is an autosomal recessive disorder characterized both by deafness and blindness. For the three clinical subtypes of Usher syndrome causal mutations in altogether 12 genes and a modifier gene have been identified. Due to the genetic heterogeneity of Usher syndrome, the molecular analysis is predestined for a comprehensive and parallelized analysis of all known genes by next-generation sequencing (NGS) approaches. We describe here the targeted enrichment and deep sequencing for exons of Usher genes and compare the costs and workload of this approach compared to Sanger sequencing. We also present a bioinformatics analysis pipeline that allows us to detect single-nucleotide variants, short insertions and deletions, as well as copy number variations of one or more exons on the same sequence data. Additionally, we present a flexible in silico gene panel for the analysis of sequence variants, in which newly identified genes can easily be included. We applied this approach to a cohort of 44 Usher patients and detected biallelic pathogenic mutations in 35 individuals and monoallelic mutations in eight individuals of our cohort. Thirty-nine of the sequence variants, including two heterozygous deletions comprising several exons of USH2A, have not been reported so far. Our NGS-based approach allowed us to assess single-nucleotide variants, small indels, and whole exon deletions in a single test. The described diagnostic approach is fast and cost-effective with a high molecular diagnostic yield.

Indexed as

Gene panel diagnosticsnext-generation sequencingUsher syndrome

Identifiers

PMID25333064
PMCPMC4190874
OpenAlexW2089548728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.